Concepedia

H.R. Kim

HK

1

Publications

89

Citations

1

H-Index

2019

Active since

Affiliations

Sungkyunkwan University(Current)

H.R. Kim is an author at Sungkyunkwan University specializing in cancer therapeutics, lung cancer, and medicine.

Top concepts

Publications per year

2019–2019

1

Publications

1

Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study

Taofeek K. Owonikoko, H.R. Kim, Ramaswamy Govindan et al. · Annals of Oncology · 2019 · 89 citations · Full text

, , +8

Rows per page

1–1 of 1